Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996. | ||||||
Gamida Cell is a biotechnology company developing cell therapies for treating cancer and hematologic diseases. | ||||||
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases | ||||||
Verona Pharma is a London-based biotechnology company working to discover new drugs for the treatment of chronic respiratory diseases. | ||||||
Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind | ||||||
Dicerna Pharmaceuticals is a company that focuses on the discovery and development of treatments for inherited diseases. | ||||||
Disc Medicine is a medical research company that develops treatments for hematologic diseases. | ||||||
Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines. | ||||||
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth. | ||||||
Day One Biopharmaceuticals is a cancer Treatments founded in 2018. | ||||||
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases. | ||||||
Eliem Therapeutics is a treatments for neuronal Excitability Disorders. | ||||||
At Upstream Bio we strive to reach the source of inflammation and conquer it. We are leveraging our diverse roots and the team's substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. | ||||||
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain. | ||||||
Centessa companies are advancing a portfolio of high conviction programs with strong biological validation | ||||||
Areteia Therapeutics, Inc. is a Short Hills, New Jersey-based company founded in 2022. | ||||||
Perfuse Therapeutics, Inc. is a therapies for Eye Disease founded in 2018. |